NCT06043921View on ClinicalTrials.gov

Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Pancreatic Cancer
Interventions
OTHER

No intervention

There is no intervention associated with this observational study.

Trial Locations (1)

Unknown

RECRUITING

National Cancer Center Hospital East, Kashiwa

Sponsors
All Listed Sponsors
collaborator

National Cancer Center Hospital East

OTHER

lead

Invitae Corporation

INDUSTRY